Literature DB >> 34296322

On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes.

James D Johnson1,2.   

Abstract

Hundreds of millions of people are affected by hyperinsulinaemia, insulin resistance, obesity and the dysglycaemia that mark a common progression from metabolic health to type 2 diabetes. Although the relative contribution of these features and the order in which they appear may differ between individuals, the common clustering and seemingly progressive nature of type 2 diabetes aetiology has guided research and clinical practice in this area for decades. At the same time, lively debate around the causal relationships between these features has continued, as new data from human trials and highly controlled animal studies are presented. This 'For debate' article was prompted by the review in Diabetologia by Esser, Utzschneider and Kahn ( https://doi.org/10.1007/s00125-020-05245-x ), with the purpose of reviewing established and emerging data that provide insight into the relative contributions of hyperinsulinaemia and impaired glucose-stimulated insulin secretion in progressive stages between health, obesity and diabetes. It is concluded that these beta cell defects are not mutually exclusive and that they are both important, but at different stages.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Dysglycaemia; Human studies; Hyperinsulinaemia; Insulin resistance; Insulin secretion; Mouse models; Obesity; Pancreatic islet beta cells; Review; Type 2 diabetes

Mesh:

Substances:

Year:  2021        PMID: 34296322     DOI: 10.1007/s00125-021-05505-4

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  71 in total

1.  Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes.

Authors:  Robert Wagner; Martin Heni; Adam G Tabák; Jürgen Machann; Fritz Schick; Elko Randrianarisoa; Martin Hrabě de Angelis; Andreas L Birkenfeld; Norbert Stefan; Andreas Peter; Hans-Ulrich Häring; Andreas Fritsche
Journal:  Nat Med       Date:  2021-01-04       Impact factor: 53.440

Review 2.  Diabetes mellitus and genetically programmed defects in beta-cell function.

Authors:  G I Bell; K S Polonsky
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

Review 3.  Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift.

Authors:  Christopher J Nolan; Marc Prentki
Journal:  Diab Vasc Dis Res       Date:  2019-02-15       Impact factor: 3.291

Review 4.  The Carbohydrate-Insulin Model of Obesity: Beyond "Calories In, Calories Out".

Authors:  David S Ludwig; Cara B Ebbeling
Journal:  JAMA Intern Med       Date:  2018-08-01       Impact factor: 21.873

Review 5.  Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia.

Authors:  Nathalie Esser; Kristina M Utzschneider; Steven E Kahn
Journal:  Diabetologia       Date:  2020-09-07       Impact factor: 10.122

6.  Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects.

Authors:  K S Polonsky; B D Given; E Van Cauter
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

Review 7.  Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse?

Authors:  Michael H Shanik; Yuping Xu; Jan Skrha; Rachel Dankner; Yehiel Zick; Jesse Roth
Journal:  Diabetes Care       Date:  2008-02       Impact factor: 19.112

8.  Banting lecture 2011: hyperinsulinemia: cause or consequence?

Authors:  Barbara E Corkey
Journal:  Diabetes       Date:  2012-01       Impact factor: 9.461

9.  Determinants of High Fasting Insulin and Insulin Resistance Among Overweight/Obese Adolescents.

Authors:  Jerri Chiu Yun Ling; Mohd Nahar Azmi Mohamed; Muhammad Yazid Jalaludin; Sanjay Rampal; Nur Lisa Zaharan; Zahurin Mohamed
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

10.  Diabetes: have we got it all wrong? Hyperinsulinism as the culprit: surgery provides the evidence.

Authors:  Walter J Pories; G Lynis Dohm
Journal:  Diabetes Care       Date:  2012-12       Impact factor: 19.112

View more
  11 in total

Review 1.  Precision nutrition in diabetes: when population-based dietary advice gets personal.

Authors:  Jordi Merino
Journal:  Diabetologia       Date:  2022-05-20       Impact factor: 10.460

Review 2.  Trends in insulin resistance: insights into mechanisms and therapeutic strategy.

Authors:  Mengwei Li; Xiaowei Chi; Ying Wang; Sarra Setrerrahmane; Wenwei Xie; Hanmei Xu
Journal:  Signal Transduct Target Ther       Date:  2022-07-06

3.  Very-Long-Chain Unsaturated Sphingolipids Mediate Oleate-Induced Rat β-Cell Proliferation.

Authors:  Anne-Laure Castell; Alexis Vivoli; Trevor S Tippetts; Isabelle Robillard Frayne; Zuraya Elisa Angeles; Valentine S Moullé; Scott A Campbell; Matthieu Ruiz; Julien Ghislain; Christine Des Rosiers; William L Holland; Scott A Summers; Vincent Poitout
Journal:  Diabetes       Date:  2022-06-01       Impact factor: 9.337

Review 4.  Pulsatile Basal Insulin Secretion Is Driven by Glycolytic Oscillations.

Authors:  P A Fletcher; I Marinelli; R Bertram; L S Satin; A S Sherman
Journal:  Physiology (Bethesda)       Date:  2022-04-04

Review 5.  The insulin centennial-100 years of milestones in biochemistry.

Authors:  Alan D Attie; Qi-Qun Tang; Karin E Bornfeldt
Journal:  J Lipid Res       Date:  2021-10-28       Impact factor: 5.922

6.  Empagliflozin protects diabetic pancreatic tissue from damage by inhibiting the activation of the NLRP3/caspase-1/GSDMD pathway in pancreatic β cells: in vitro and in vivo studies.

Authors:  Pan Liu; Zhengdong Zhang; Jinwu Wang; Xiao Zhang; Xiaoping Yu; Yao Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

7.  Peptide Model of the Mutant Proinsulin Syndrome. II. Nascent Structure and Biological Implications.

Authors:  Yanwu Yang; Michael D Glidden; Balamurugan Dhayalan; Alexander N Zaykov; Yen-Shan Chen; Nalinda P Wickramasinghe; Richard D DiMarchi; Michael A Weiss
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-01       Impact factor: 5.555

Review 8.  Macrophages, Low-Grade Inflammation, Insulin Resistance and Hyperinsulinemia: A Mutual Ambiguous Relationship in the Development of Metabolic Diseases.

Authors:  Gerhard Paul Püschel; Julia Klauder; Janin Henkel
Journal:  J Clin Med       Date:  2022-07-27       Impact factor: 4.964

9.  Prohormone convertase 1/3 deficiency causes obesity due to impaired proinsulin processing.

Authors:  Daniel T Meier; Leila Rachid; Sophia J Wiedemann; Shuyang Traub; Kelly Trimigliozzi; Marc Stawiski; Loïc Sauteur; Denise V Winter; Christelle Le Foll; Catherine Brégère; Raphael Guzman; Alex Odermatt; Marianne Böni-Schnetzler; Marc Y Donath
Journal:  Nat Commun       Date:  2022-08-13       Impact factor: 17.694

10.  Rapamycin/metformin co-treatment normalizes insulin sensitivity and reduces complications of metabolic syndrome in type 2 diabetic mice.

Authors:  Peter C Reifsnyder; Kevin Flurkey; Rosalinda Doty; Nigel A Calcutt; Robert A Koza; David E Harrison
Journal:  Aging Cell       Date:  2022-08-19       Impact factor: 11.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.